Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic Mycobacterium avium complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): study protocol

Introduction Standard treatment for nodular/bronchiectatic Mycobacterium avium complex lung disease (NB MAC-LD), excluding severe-status cases, differs between Japan and other countries. Internationally, three-drug combination intermittent treatment (three times a week administration) with macrolide...

Полное описание

Библиографические подробности

Главные авторы:	Akiko M Saito, Yoshikazu Inoue, Taku Nakagawa, Hiroya Hashimoto, Mitsuaki Yagi, Yoshihito Kogure, Masahiro Sekimizu, Kenji Ogawa
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMJ Publishing Group 2019-10-01
Серии:	BMJ Open Respiratory Research
Online-ссылка:	https://bmjopenrespres.bmj.com/content/6/1/e000434.full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!